PR Newswire NEW YORK, Jan. 10, 2025 Novel siRNA Therapeutic Demonstrates Significant Fat Loss and Remarkable Lean Body Mass Preservation, and Promises Superior Adherence NEW YORK, Jan. 10, 2025 /PRNewswire/ - Canary Cure Therapeutics, a ...
PR Newswire HUNTINGTON, N.Y., Jan. 9, 2025 HUNTINGTON, N.Y., Jan. 9, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a leader in innovative anti-inflammatory care, today announced the submission of a new patent application that introduces a ...
PR Newswire SAN DIEGO, Jan. 8, 2025 13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...
PR Newswire NEW YORK, Dec. 26, 2024 Hoth Therapeutics Enters Exclusive Patent License Agreement with VA and Emory University Hoth Also Expands Its' Intellectual Property to Further Its' Market Opportunity for HT-001 NEW YORK, Dec. ...
PR Newswire SILVER SPRING, Md., Dec. 20, 2024 SILVER SPRING, Md., Dec. 20, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...
PR Newswire INDIANAPOLIS, Dec. 20, 2024 Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms ...
PR Newswire HONG KONG, Dec. 18, 2024 HONG KONG, Dec. 18, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging efficacy results from its study in diet-induced obese (DIO) mice combining ASC47, a ...
PR Newswire LEHI, Utah, Dec. 9, 2024 Study Demonstrates 16.6 % at day 7 to 29 % on terminal day 28 Weight Loss and Superior Efficacy Compared to peptide-based approved or clinical stage oral Obesity Drugs in the DIO Model LEHI, Utah, ...
PR Newswire LEHI, Utah, Dec. 5, 2024 LEHI, Utah, Dec. 5, 2024 /PRNewswire/ -- Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for chronic inflammatory ...
PR Newswire CHATTANOOGA, Tenn., Dec. 2, 2024 A Better Way to Manage Weight CHATTANOOGA, Tenn., Dec. 2, 2024 /PRNewswire/ -- It has been estimated that 74 percent of adults are overweight, and 43 percent are obese. Obesity leads to other ...
Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.
Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.
The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.
Losing a lot of weight provides long-term health benefits, even if some weight is regained.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers